arbekacin has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamazaki, H; Hasegawa, H; Horiuchi, A; Kageyama, T; Kanayama, Y; Kitani, T; Masaoka, T; Sugiyama, H; Tatsumi, N; Uchino, H | 1 |
| Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
1 review(s) available for arbekacin and Leukemia
| Article | Year |
|---|---|
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
1 trial(s) available for arbekacin and Leukemia
| Article | Year |
|---|---|
[Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |